May. 17 at 10:12 PM
$MDGL "Resmetirom [Rezdiffra], a drug approved by the U.S. Food and Drug Administration (FDA) to treat metabolic dysfunction associated fatty liver disease (MAFLD), may offer benefits beyond reducing liver fat and fibrosis, according to a new study published in the journal Hepatology. Researchers found the drug may also help prevent and suppress liver cancer linked to fatty liver disease." https://scitechdaily.com/scientists-uncover-cancer-fighting-power-of-popular-fatty-liver-drug/
